Showing 6,161 - 6,180 results of 28,667 for search '(( 5 ((ng decrease) OR (nn decrease)) ) OR ( 50 ((we decrease) OR (a decrease)) ))', query time: 0.85s Refine Results
  1. 6161
  2. 6162
  3. 6163
  4. 6164
  5. 6165
  6. 6166
  7. 6167
  8. 6168

    Rho inactivation negatively affects biofilm formation in <i>B</i>. <i>subtilis</i>. by Vladimir Bidnenko (4258573)

    Published 2017
    “…RT-PCR analysis of rRNA (bottom section) was used as a control. Synthesis of cDNA was performed using 50 ng of total RNA as template (<a href="http://www.plosgenetics.org/article/info:doi/10.1371/journal.pgen.1006909#sec019" target="_blank">Materials and methods</a>). …”
  9. 6169
  10. 6170
  11. 6171
  12. 6172
  13. 6173
  14. 6174

    ACE conformation in lung cancer (conformational fingerprinting of ACE). by Sergei M. Danilov (7924736)

    Published 2019
    “…Ratio increased more than 20% are highlighted with orange, more than 50% -with brown and more than 100%—with red. Bars highlighted with yellow- ratio decreased more than 20%, with blue—decreased more than 50%. …”
  15. 6175
  16. 6176

    Table 1_Changes in circulating NK and innate-like T cells in type 1 and type 2 diabetes.docx by Marina Loguinova (3552146)

    Published 2025
    “…Also a 50% increase in frequency of CD8+ NK cells was observed together with a growth of CD8+CD38+, CD8+CD161+, CD8+NKG2A+, and CD8+EOMES+ NK subsets. …”
  17. 6177

    Table 2_Changes in circulating NK and innate-like T cells in type 1 and type 2 diabetes.xlsx by Marina Loguinova (3552146)

    Published 2025
    “…Also a 50% increase in frequency of CD8+ NK cells was observed together with a growth of CD8+CD38+, CD8+CD161+, CD8+NKG2A+, and CD8+EOMES+ NK subsets. …”
  18. 6178

    Design and Synthesis of Novel Epigenetic Inhibitors Targeting Histone Deacetylases, DNA Methyltransferase 1, and Lysine Methyltransferase G9a with <i>In Vivo</i> Efficacy in Multip... by Obdulia Rabal (124515)

    Published 2021
    “…Concomitant inhibition of key epigenetic pathways involved in silencing tumor suppressor genes has been recognized as a promising strategy for cancer therapy. Herein, we report a first-in-class series of quinoline-based analogues that simultaneously inhibit histone deacetylases (from a low nanomolar range) and DNA methyltransferase-1 (from a mid-nanomolar range, IC<sub>50</sub> < 200 nM). …”
  19. 6179
  20. 6180